CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.24

EPS Forecast

$5.5

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-12-31
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncRGENRepligen CorpTECHBio-techne CorpMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc